PCM
GOSS icon

Penserra Capital Management’s Gossamer Bio GOSS Stock Holding History

Penserra Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$21K – 1434
2021
Q3 		$21K Hold
22
– – ﹤0.01% 1235
2021
Q2 		$14K Buy
22
+1
+5% +$694 ﹤0.01% 1237
2021
Q1 		$15K Sell
21
-1
-5% -$807 ﹤0.01% 993
2020
Q4 		$16K Buy
22
+14
+175% +$11K ﹤0.01% 875
2020
Q3 		$8K Buy
+8
New +$8.48K ﹤0.01% 836

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Penserra Capital Management's GOSS Position: Q4 2021 in Review

Penserra Capital Management sold out of Gossamer Bio (GOSS) in Q4 2021, closing a stake of 22 shares — an estimated $21K sold.

Penserra Capital Management first reported a position in GOSS in Q3 2020 and held it in 5 quarters. The position peaked at $21K in Q3 2021. 131 funds tracked by Wall St. Rank hold GOSS as of Q4 2021.

  • Penserra Capital Management reported no remaining Gossamer Bio position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 22 Gossamer Bio shares in Q4 2021, an estimated $21K.
  • Penserra Capital Management first reported a position in Gossamer Bio in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Gossamer Bio position peaked at $21K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.